Article Information
History
- April 30, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Stacey A. Lapp1,2,
- Venkata Viswanadh Edara1,2,3,
- Austin Lu1,2,
- Lilin Lai1,2,3,
- Laila Hussaini1,2,
- Ann Chahroudi1,2,
- Larry J. Anderson1,2,
- Mehul S. Suthar1,2,3,
- Evan J. Anderson1,2,4 and
- Christina A. Rostad1,2,*
- 1Department of Pediatrics, Emory University School of Medicine, Atlanta, GA USA
- 2Center for Childhood Infections and Vaccines, Children’s Healthcare of Atlanta and Emory University School of Medicine, Atlanta, GA USA
- 3Yerkes Primate Center, Emory University, Atlanta, GA USA
- 4Department of Medicine, Emory University School of Medicine, Atlanta, GA USA
- ↵*Corresponding Author: Christina.rostad{at}emory.edu (CAR)
Author Contributions: SAL and CAR contributed to study conceptualization, funding acquisition, resources, data curation, investigation, and original drafting of the manuscript. AL, LH, and EJA contributed to data curation. LJA, EJA, AC contributed to study conceptualization, funding acquisition and resources. MSS, VE, and LL contributed to study investigation by performing neutralizing antibody experiments. All authors contributed to writing, review, and editing of the manuscript.
Posted April 30, 2021.
Original antigenic sin responses to heterologous Betacoronavirus spike proteins are observed in mice following intramuscular administration, but are not apparent in children following SARS-CoV-2 infection
